Aurobindo Pharma Limited (AUROPHARMA)
₹1,120.5
INR+16.30(+1.48%)
As of June 25, 2025 9:33:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹63870.79 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹63873.55 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
18.39
Forward P/E
Price to Earnings ratio based on forecasted earnings
17.65
PEG Ratio
Price/Earnings to Growth ratio
17.65
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
2.01
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
59.10%
Operating Margin
Operating income as a percentage of revenue
16.08%
Return on Equity
Net income as a percentage of shareholders' equity
11.15%
Revenue (TTM)
Total revenue over trailing 12 months
₹31723.73 Cr+10.6%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹7172.95 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹59.80-0.6%
Balance Sheet
Total Cash
Total cash and short-term investments
₹8235.50 Cr
Total Debt
Total short-term and long-term debt
₹8262.87 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
25.31%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹1010 - ₹1592
Beta
Measure of stock's volatility compared to the market
0.22
Shares Outstanding
Total number of shares issued by the company
₹58.08 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
23.11%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
34.67%
Payout Ratio
Percentage of earnings paid as dividends
NA
